Long-term Follow-Up of Participants of the Phase II study to evaluate subcutaneous abatacept vs placebo in diffuse cutaneous systemic sclerosis - a double-blind, placebo-controlled, randomized trial
|Effective start/end date||1/1/19 → 12/31/24|
- University of Michigan
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.